melanoma News
-
‘Don’t Fry Day’ promotes skin cancer prevention; EPA urges everyone to be smart in the sun [NJ Edition]
As millions of families prepare to enjoy the great outdoors this weekend, the U.S. Environmental Protection Agency (EPA) reminds everyone to bring their hats, sunglasses and sunscreen, and seek shade. The number one preventable risk factor for skin cancer is overexposure to ultraviolet (UV) radiation, whether from the sun or artificial sources of light. To educate the public about how to prevent ...
-
People with Parkinson’s Disease may have double the risk for Melanoma, a dangerous skin cancer
An analysis of several studies shows that people with Parkinson’s disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases. The research is published in the June 7, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. Parkinson’s disease is a brain disorder ...
-
Data Presentations at 2023 Winter Clinical Dermatology Conference - Hawaii Support Clinical Value of Castle Biosciences’ Skin Cancer Test Portfolio
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data supporting the clinical value of the Company’s skin cancer test portfolio is being shared in poster presentations at the 2023 Winter Clinical Dermatology Conference - Hawaii®, being held Jan. 13-18 in Kohala Coast, Hawaii. “At Castle, ...
-
EPA urges everyone to play it safe in the summer sun
As millions of families prepare to enjoy the great outdoors this weekend, the U.S. Environmental Protection Agency reminds everyone to bring their hats, sunglasses, sunscreen, and seek shade. Why? Because overexposure to ultraviolet radiation (UV) from the sun or artificial light is the number one risk factor for skin cancer. By taking these simple steps you can significantly reduce your risk. ...
-
People with Parkinson’s disease may have double the risk for melanoma, a dangerous skin cancer
An analysis of several studies shows that people with Parkinson’s disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases. The research is published in the June 7, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. Parkinson’s disease is a brain disorder ...
-
Evaxion Biotech Announces Publication of Clinical Data of EVX-01 Heading into Phase 2b in Collaboration with Merck
Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the publication of a paper on personalized therapy with EVX-01 in patients with metastatic melanoma in the open access, peer-reviewed journal OncoImmunology. The paper, ...
-
Evaxion Biotech Receives Regulatory Clearance to Initiate Phase 2 Trial of EVX-01 in Combination with KEYTRUDA® for Treatment of Melanoma
Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today it has received clearance from the Australia Therapeutic Goods Administration to initiate a Phase 2b trial of its patient specific cancer immunotherapy EVX-01 in combination ...
-
Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update
Expect to close our follow-on public offering (FPO) of 3,942,856 ordinary shares represented by American Depositary Shares (ADSs) for gross proceeds of $27.6 million before deducting underwriter fees and commissions and other offering expenses Data reported in early July 2021 from EVX-01 Phase 1/2a clinical trial showed a robust anti-tumor effect in combination with anti-PD-1 treatment for ...
-
EPA raises awareness on skin cancer prevention with “Don’t Fry Day” campaign agency urges everyone to be smart in the sun
As millions of families prepare to enjoy the great outdoors over the Memorial Day weekend, the U.S. Environmental Protection Agency (EPA) reminds everyone to bring their hats, sunglasses and sunscreen, and seek shade. EPA has teamed up with the National Council on Skin Cancer Prevention to promote sun safety on May 28 – “Don’t Fry Day.” The number one preventable risk ...
-
Solubilization of an hydrophobic API for anti-cancer treatment
Poor water solubility is one of the most significant barrier limiting drug development. Indeed, more than 40% of compounds identified through combinatorial screening programs display poor aqueous solubility, which is associated with poor bioavailability, suboptimal dosing, etc. Adjuvatis uses a safe-by-design technology that allows formulation of APIs with little or no solubility. Adjuvatis ...
By Adjuvatis
-
EPA region 10 asks oregonians to fight #1 cancer in U.S. with “don’t fry day” (Friday, May 27)
Every hour, one American dies from skin cancer – the number one cancer in the U.S. To help people learn easy ways to combat the disease, the U.S. EPA SunWise program has partnered with the National Council on Skin Cancer Prevention to designate the Friday before Memorial Day (May 27) as “Don’t Fry Day.” EPA encourages Oregonians to learn about and practice sun-safe ...
-
EPA region 10 asks idaho residents to fight #1 cancer in U.S. with “don’t fry day” (Friday, May 27)
Every hour, one American dies from skin cancer – the number one cancer in the U.S. To help people learn easy ways to combat the disease, the U.S. EPA SunWise program has partnered with the National Council on Skin Cancer Prevention to designate the Friday before Memorial Day (May 27) as “Don’t Fry Day.” EPA encourages Idaho residents to learn about and practice sun-safe ...
-
EPA asks Pennsylvania residents to be sun-wise and sun-safe this summer
Every hour, one American dies from skin cancer – the number one cancer in the U.S. To help people learn easy ways to combat the disease, the U.S. EPA SunWise program has partnered with the National Council on Skin Cancer Prevention to designate today, the Friday before Memorial Day, as “Don’t Fry Day.” EPA encourages Pennsylvania residents practice sun-safe behaviors to ...
-
EPA region 10 asks washington residents to fight #1 cancer in U.S. with “don’t fry day” (Friday, May 27)
Every hour, one American dies from skin cancer – the number one cancer in the U.S. To help people learn easy ways to combat the disease, the U.S. EPA SunWise program has partnered with the National Council on Skin Cancer Prevention to designate the Friday before Memorial Day (May 27) as “Don’t Fry Day.” EPA encourages Washington residents to learn about and practice ...
-
Enjoy summer weather in New England: ‘Don’t Fry’ to prevent skin cancer
With Memorial Day weekend signaling the unofficial start of New England’s long-awaited summer, EPA reminds everyone to protect their skin from too much sun by wearing hats, sunglasses and sunscreen, and seeking shade. “Even as we all enjoy the good weather this time of year, and we want to enjoy some of New England’s splendid natural areas, we remind folks to protect their ...
-
New Englanders Reminded that skin cancer is most common, and most preventable cancer in U.S. - sun safety tips for `Don’t Fry Day`: May 25, 2012
With the traditional Memorial Day kick off to summertime activities, EPA is reminding New England citizens and visitors about simple steps to take to protect their skin from too much sun exposure. This year EPA has teamed up with the National Council on Skin Cancer Prevention, Food and Drug Administration and National Park Service to emphasize the dangers of skin cancer. The National Council on ...
-
Castle Biosciences Receives Accreditation from the College of American Pathologists for its Pittsburgh Clinical Laboratory
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Accreditation Committee of the College of American Pathologists (CAP) has accredited its clinical laboratory facility in Pittsburgh. This achievement follows a recent on-site inspection as part of the CAP’s Laboratory Accreditation Program. ...
-
Obsidian Therapeutics To Present Preclinical Data From cytoTIL15 Program at the European Society for Medical Oncology Congress 2021
Obsidian Therapeutics, a biotechnology company pioneering engineered cell and gene therapies, today announced that the Company will present data highlighting its cytoTIL15™ program at the upcoming European Society for Medical Oncology (ESMO) Congress, which will be hosted virtually September 16-21, 2021. The abstract for the poster describes how Obsidian’s cytoTIL15 product (TIL ...
-
Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology
Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces that MB097 is now in pre-clinical development for treatment of patients not responding to anti-PD1 therapy. Clinical trials are due to begin in 2022. MB097 is clinically designed and experimentally validated. Studies have shown that the gut microbiome plays a critical and causative role in determining ...
-
A drug that inhibits gastric acid secretion Omeprazole CAS:73590-58-6
Omeprazole is a proton pump inhibitor that can effectively inhibit gastric acid secretion. The trade names in circulation on the market include ampirazole omilazole, maidazole loseke, methoxesulfazolvobisole, vompirazole, which belongs to the acid-suppressant drugs, and common acid-suppressant drugs also include pantoprazole, rabeprazole Nexomepazole selectively acts on gastric mucosal parietal ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you